Artificial intelligence-focused healthcare technology company Gauss partnered with Cellex, a biotech company specializing in point-of-care diagnostic testing, to create the first rapid COVID-19 ...

In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...

New findings demonstrate how the rapid antigen test can be used to triage healthcare workers for returning to work during periods of acute staffing shortages during COVID surges. They also show that a ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

A person can still get COVID-19 and test positive after having a vaccination or booster, but this will not be due to the vaccine. The COVID-19 vaccine cannot stop a person getting the virus, but the ...

Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective tools for the diagnosis of acute infection, particularly when used serially. 1 The percentage of ...